# PDS Biotechnology Corp: Form 8-K, filed Sep 14, 2026

- Company: [PDS Biotechnology Corp](/companies/pdsb.md) (CIK 1472091)
- Form: 8-K
- Filed: 2026-09-14
- Accepted by EDGAR: Sep 14, 2026, 20:10 ET
- Period: 2026-09-12
- Accession: 0001140361-26-036489
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1472091/000114036126036489/ef20081956_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1472091/000114036126036489/

## Items reported

- Item 1.02: Termination of a material agreement
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1472091/000114036126036489/ef20081956_8k.htm

Filed Sep 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-036489. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.